National Institute of Allergy and Infectious Diseases

UAB Drug Remdesivir Is First to Block the COVID-19 Virus, May Become Standard of Care. Fauci “Optimistic.”

Remdesivir, a drug developed through a federal grant to UAB, may be the first effective therapy for treating severely ill COVID-19 patients, early analysis of a large federally sponsored study found this week.

UAB To Test Potential COVID-19 Vaccine

The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.

UAB Leads a New Anti-Viral Drug Trial to Combat the Coronavirus

The University of Alabama at Birmingham is leading a new anti-viral drug trial in Wuhan, China to combat the coronavirus outbreak.